Home > Boards > US Listed > Biotechs > NantKwest (NK)

In Here..Going for Broke..

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
jobilly Member Profile
 
Followed By 11
Posts 2,206
Boards Moderated 0
Alias Born 02/12/08
160x600 placeholder
Annual Report (10-k) Edgar (US Regulatory) - 3/25/2020 4:11:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/24/2020 5:48:16 PM
NantKwest Doses First Patient in Phase 2 Single-Arm Trial of Metastatic Merkel Cell Carcinoma Therapy With Off-the-Shelf CD16... Business Wire - 3/19/2020 8:00:00 AM
Progress Report on Cancer Breakthroughs 2020 Project Presented by Dr. Soon-Shiong at J.P. Morgan Healthcare Conference Business Wire - 1/16/2020 8:00:00 AM
NantKwest & ImmunityBio Present Results of Landmark Trial of First-in-Human Natural Killer Cell Combination Immunotherapy Wit... Business Wire - 12/16/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/12/2019 6:30:19 PM
NantKwest Announces Phase 1 Results for First-in-Human PD-L1 Tumor-Targeted Natural Killer Cells (PD-L1.t-haNK) in Patients w... Business Wire - 12/2/2019 4:05:00 PM
NantKwest Hosting Key Opinion Leader Meeting on Novel Immunotherapeutic Approaches to Address the Unmet Medical Needs of Pati... Business Wire - 11/27/2019 8:00:00 AM
NantKwest Announces Presentation of Positive Phase 2 Clinical Data of Natural Killer Cell Therapy in Metastatic Merkel Cell C... Business Wire - 11/7/2019 4:15:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2019 4:08:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/9/2019 4:43:47 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/4/2019 6:01:00 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/23/2019 4:10:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/7/2019 4:05:50 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/7/2019 4:02:57 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2019 4:09:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/5/2019 5:47:09 PM
NantKwest Launches First-in-class, First-in-human Phase I Clinical Trial With a Targeted PD-L1 t-haNK Cell Therapy in Patient... Business Wire - 6/24/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2019 4:04:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:48:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:45:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:42:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:40:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:36:37 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/7/2019 4:32:37 PM
jobilly   Friday, 03/08/19 01:43:06 PM
Re: None
Post # of 1258 
In Here..Going for Broke..

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist